Long-term Follow Up of Viral Hepatitis in Uremic Patients in Taiwan
2 other identifiers
observational
1,600
1 country
1
Brief Summary
The linkage between viral hepatitis and renal failure is complex. The current study aims to exlore the long-term prevalence of viral hepatitis among uremic patients in Taiwan
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 1, 2013
CompletedFirst Posted
Study publicly available on registry
January 11, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2021
CompletedMarch 5, 2019
March 1, 2019
10 years
January 1, 2013
March 2, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
seroprevalence of viral hepatitis in uremic patients
10 years
Secondary Outcomes (1)
factors associated with HCV clearance or reappearance
10 years
Other Outcomes (1)
HBV seroconversion
10 years
Study Arms (1)
uremic patients
blood sampling of viral hepatitis in uremic patients
Interventions
blood sampling of viral hepatitis to determined seroprevalence in uremic patients
Eligibility Criteria
Uremic patients will recruited from 15 hemodialysis units including one medical center, 3 satellite hospitals and 11 local clinics in Taiwan.
You may qualify if:
- uremic patients
You may not qualify if:
- Nil
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Medical University Hospital
Kaohsiung City, 886, Taiwan
Related Publications (1)
Wei YJ, Hsu PY, Lee JJ, Niu SW, Huang JC, Hsu CT, Jang TY, Yeh ML, Huang CI, Liang PC, Lin YH, Hsieh MY, Hsieh MH, Chen SC, Dai CY, Lin ZY, Chen SC, Huang JF, Chang JM, Hwang SJ, Chuang WL, Huang CF, Chiu YW, Yu ML. Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group. J Viral Hepat. 2021 May;28(5):719-727. doi: 10.1111/jvh.13477. Epub 2021 Feb 13.
PMID: 33533547DERIVED
Biospecimen
host factors ssociated with viral hepatitis
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chung-Feng Huang, M.D.
Kaohsiung Medical University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 1, 2013
First Posted
January 11, 2013
Study Start
January 1, 2011
Primary Completion
January 1, 2021
Study Completion
January 1, 2021
Last Updated
March 5, 2019
Record last verified: 2019-03